Compare Hinge Health Inc. Class A Common Stock (HNGE) vs Wix.Com Ltd (WIX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Hinge Health Inc. Class A Common Stock vs Wix.Com Ltd — how do they compare? Hinge Health Inc. Class A Common Stock trades at $103.99 (market cap $8.47B), while Wix.Com Ltd trades at $74.09 (market cap $3.11B). The key difference: Hinge Health Inc. Class A Common Stock is far larger — about 2.7× Wix.Com Ltd's market cap, and Hinge Health Inc. Class A Common Stock is trading nearer its 52-week high, Wix.Com Ltd nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Hinge Health Inc. Class A Common Stock for 0 Days and Wix.Com Ltd for 62 Days on average.
| HNGE | WIX | |
|---|---|---|
Market Cap | $8.47B | $3.11B |
Volume | 1,624,526 | 736,895 |
Sector | Health | Technology |
52-Week High | $105.14 | $145.54 |
52-Week Low | $31.17 | $40.43 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $8.09B | $4.19B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Hinge Health (HNGE) trades at $105.14, up 0.31% on the day and near its 52-week high. The stock shows strong analyst support with a 93.75% buy rating, though the current price exceeds the consensus target of $101.62. Recent earnings beat expectations in two of the last three quarters, with Q3 2026 results due November 2. Fundamentals indicate robust revenue growth projections from $588 million in 2025 to $720 million in 2026, alongside a shift to profitability, but valuation multiples like EV/EBITDA at 82.33 remain elevated.
The outlook is cautiously optimistic given projected profitability and expansion into migraine and GI care, but risks include high insider selling, competitive pressures, and the stock's premium valuation. Execution on growth targets and Q3 earnings will be critical for sustaining momentum.
WIX trades at $71.74, down 3.28% today, amid a bearish technical signal and negative net cash flow. Revenue grew to $1.99B in 2025, but net income fell to $50.65M with a negative margin. Analyst consensus is bullish with a $77.00 price target, though recent class action lawsuits have dampened sentiment.
The outlook is mixed: strong revenue growth and analyst support offer upside, but profitability concerns, litigation risks, and negative equity pose significant challenges. Investors should weigh the high P/E ratio against potential operational improvements.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Hinge Health Inc. Class A Common Stock
Hinge Health Inc. operates a digital musculoskeletal (MSK) care platform that delivers exercise therapy for joint and muscle conditions through health plans and employers. Its Precision Motion Technology combines wearable sensors and computer vision to guide patients through clinician-directed physical therapy remotely.
Read more on HNGE →About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →
